Total submissions: 3
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Invitae | RCV000497168 | SCV001643308 | likely benign | Neurofibromatosis, type 1 | 2020-01-19 | criteria provided, single submitter | clinical testing | |
Ambry Genetics | RCV002356813 | SCV002660383 | uncertain significance | Hereditary cancer-predisposing syndrome; Cardiovascular phenotype | 2021-10-07 | criteria provided, single submitter | clinical testing | The c.615G>A variant (also known as p.K205K) is located in coding exon 6 of the NF1 gene. This variant results from a G to A substitution at nucleotide position 615. This nucleotide substitution does not change the lysine at codon 205. This alteration was identified in an individual from a neurofibromatosis type 1 cohort (Bonatti F et al. Int J Mol Sci, 2017 Sep;18:). This nucleotide position is well conserved in available vertebrate species. In silico splice site analysis predicts that this alteration will not have any significant effect on splicing; however direct evidence is insufficient at this time (Ambry internal data). Since supporting evidence is limited at this time, the clinical significance of this alteration remains unclear. |
Medical Genetics, |
RCV000497168 | SCV000588702 | uncertain significance | Neurofibromatosis, type 1 | 2017-02-02 | no assertion criteria provided | clinical testing |